Assembly Biosciences, Inc
ASMB Real Time Price USDRecent trades of ASMB by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ASMB's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: 5-membered heteroaryl carboxamide compounds for treatment of hbv Jul. 09, 2024
-
Patent Title: Hepatitis b core protein modulators Nov. 14, 2023
-
Patent Title: 5-membered heteroaryl carboxamide compounds for treatment of hbv Jan. 24, 2023
-
Patent Title: Cyclic sulfamide compounds and methods of using same Aug. 03, 2021
-
Patent Title: Process for making hepatitis b core protein modulators Jun. 22, 2021
-
Patent Title: Process for making hepatitis b core protein modulators May. 18, 2021
-
Patent Title: Hepatitis b core protein modulators Apr. 27, 2021
-
Patent Title: Hepatitis b core protein modulators Apr. 06, 2021
-
Patent Title: Hepatitis b core protein modulators Sep. 08, 2020
-
Patent Title: Hepatitis b core protein modulators Aug. 27, 2019
-
Patent Title: Hepatitis b core protein modulators Aug. 13, 2019
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ASMB in WallStreetBets Daily Discussion
Recent insights relating to ASMB
Recent picks made for ASMB stock on CNBC
ETFs with the largest estimated holdings in ASMB
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ASMB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.